GlassScriptPhysician profile
Tejas N Parikh
NPI 1992909402
$13,798.83
in general payments reported to CMS, 2019-2025
33 companies · $2,465 in 2025
The $2,465 reported for 2025 was more than what 95% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,006 · 2020: $633 · 2021: $2,080 · 2022: $1,097 · 2023: $1,312 · 2024: $3,206 · 2025: $2,465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,444 · Travel and Lodging: $1,540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,443.55 |
| Travel and Lodging | $1,539.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $4,443.22 | 2019-2024 | Senza |
| Boston Scientific Corporation | $3,296.42 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Saluda Medical Americas, INC. | $2,395.80 | 2024-2025 | Evoke |
| Medtronic, INC. | $633.49 | 2021-2025 | Inceptiv, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Globus Medical, INC. | $576.69 | 2025 | Senza |
| Radius Health, INC. | $441.96 | 2019-2025 | Tymlos |
| Stryker Corporation | $371.92 | 2019-2025 | Mild Device Kit, Optablate, Mako |
| Medtronic USA, INC. | $212.01 | 2020 | |
| Stratus Medical, LLC | $206.83 | 2024 | Nimbus |
| Fidia Pharma USA INC. | $192.99 | 2019-2022 | |
| Relievant Medsystems, INC. | $138.13 | 2021 | |
| Orthalign INC | $113.64 | 2025 | Orthalign Plus |
| Sanofi-Aventis U.S. LLC | $98.84 | 2022-2023 | |
| Pacira Therapeutics, INC. | $96.94 | 2019-2020 | |
| Abbott Laboratories | $83.65 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $81.42 | 2025 | |
| Vertos Medical, INC. | $58.21 | 2021-2024 | Mild Device Kit |
| Curonix LLC | $57.39 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Convatec INC. | $32.01 | 2019 | |
| Myoscience INC. | $31.63 | 2019 | |
| Depuy Synthes Sales INC. | $30.19 | 2019-2024 | Orthovisc |
| Dynasplint Systems INC. | $25.74 | 2025 | Dynasplint |
| Heron Therapeutics, INC. | $24.41 | 2024 | Zynrelef |
| Smith+Nephew, INC. | $23.42 | 2025 | Pico |
| Ermi LLC | $19.45 | 2021 | |
| Kinex Medical Company LLC | $17.72 | 2019 | |
| Bioventus LLC | $16.80 | 2020 | |
| Forte Bio-Pharma LLC | $15.94 | 2024 | Prolate, Nalocet |
| Kowa Pharmaceuticals America, INC. | $15.45 | 2022 | |
| Ferring Pharmaceuticals INC. | $15.37 | 2023 | Euflexxa |
| Endo Pharmaceuticals INC. | $12.57 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $11.50 | 2020 | |
| Nalu Medical, INC. | $7.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tejas Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.